Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?

Journal of Gastrointestinal Surgery

Volumn 15, Issue 8, 2011, Pages 1440-1449

  Yu, Ming Chin ^a,b   Chan, Kun Ming ^a   Lee, Chen Fang ^a   Lee, Yun Shien ^a   Eldeen, Firas Zahr ^a   Chou, Hong Shiue ^a   Lee, Wei Chen ^a   Chen, Miin Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Alkaline phosphatase; Hepatectomy; Hepatocellular carcinoma; Prognosis

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; TUMOR MARKER;

AGED; BLOOD; CANCER INVASION; CANCER STAGING; DISEASE FREE SURVIVAL; ENZYMOLOGY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; REVIEW; TUMOR RECURRENCE;

AGED; ALKALINE PHOSPHATASE; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79960840216     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1537-3     Document Type: Review

References (23)

1. Bosch, F. X., J. Ribes, M. Diaz, and R. Cleries. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.
2. Lu, S. N., W. W. Su, S. S. Yang, T. T. Chang, K. S. Cheng, J. C. Wu, H. H. Lin, S. S. Wu, C. M. Lee, C. S. Changchien, C. J. Chen, J. C. Sheu, D. S. Chen, and C. H. Chen. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int. J. Cancer 2006; 119: 1946-1952.
3. Poon, R. T., S. T. Fan, I. O. Ng, C. M. Lo, C. L. Liu, and J. Wong. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89: 500-507.
4. Yanaga, K. Current status of hepatic resection for hepatocellular carcinoma. J. Gastroenterol. 2004; 39: 919-926.
5. Wu, J. C., Y. H. Huang, G. Y. Chau, C. W. Su, C. R. Lai, P. C. Lee, T. I. Huo, I. J. Sheen, S. D. Lee, and W. Y. Lui. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J. Hepatol. 2009; 51: 890-897.
6. Tamura, Y., M. Igarashi, T. Suda, T. Wakai, Y. Shirai, T. Umemura, E. Tanaka, S. Kakizaki, H. Takagi, Y. Hiasa, M. Onji, and Y. Aoyagi. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment. 2009; Dig. Dis. Sci. 55: 3576-83.
7. Malaguarnera, G., M. Giordano, I. Paladina, M. Berretta, A. Cappellani, and M. Malaguarnera. Serum markers of hepatocellular carcinoma. Dig. Dis. Sci. 2010; 55: 2744-55.
8. Weiss, M. J., K. Ray, P. S. Henthorn, B. Lamb, T. Kadesch, and H. Harris. Structure of the human liver/bone/kidney alkaline phosphatase gene. J. Biol. Chem. 1988; 263: 12002-12010.
9. Yeh, C. N., M. F. Chen, W. C. Lee, and L. B. Jeng. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J. Surg. Oncol. 2002; 81: 195-202.
10. Chen, M. F., H. P. Tsai, L. B. Jeng, W. C. Lee, C. N. Yeh, M. C. Yu, and C. M. Hung. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J. Surg. 2003; 27: 443-447.
11. Leung, T. W., A. M. Tang, B. Zee, W. Y. Lau, P. B. Lai, K. L. Leung, J. T. Lau, S. C. Yu, and P. J. Johnson. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002; 94: 1760-1769.
12. Qin, L. X. and Z. Y. Tang. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol. 2002; 8: 193-199.
13. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A 1998; 95: 14863-14868.
14. Pawlik, T. M., K. A. Delman, J. N. Vauthey, D. M. Nagorney, I. O. Ng, I. Ikai, Y. Yamaoka, J. Belghiti, G. Y. Lauwers, R. T. Poon, and E. K. Abdalla. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005; 11: 1086-1092.
15. Vauthey, J. N., G. Y. Lauwers, N. F. Esnaola, K. A. Do, J. Belghiti, N. Mirza, S. A. Curley, L. M. Ellis, J. M. Regimbeau, A. Rashid, K. R. Cleary, and D. M. Nagorney. Simplified staging for hepatocellular carcinoma. J. Clin. Oncol. 2002; 20: 1527-1536.
16. Lu W, Dong J, Huang Z, Guo D, Liu Y, Shi S. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol. 2008; 23: 1874-1878.
17. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, Varotti G, Cetta F, Cavallari A: Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003; 237: 536-543.
18. Chen, C. H., F. C. Hu, G. T. Huang, P. H. Lee, Y. M. Tsang, A. L. Cheng, D. S. Chen, J. D. Wang, and J. C. Sheu. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method-analysis of 2010 Taiwanese patients. 2009; Eur. J. Cancer 45: 1630-1639.
19. Tong, M. J., D. Chavalitdhamrong, D. S. Lu, S. S. Raman, A. Gomes, J. P. Duffy, J. C. Hong, and R. W. Busuttil. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. J. Clin. Gastroenterol. 2010; 44: e63-e70.
20. Sobiesiak, M., K. Sivasubramaniyan, C. Hermann, C. Tan, M. Orgel, S. Treml, F. Cerabona, P. Dezwart, U. Ochs, C. A. Muller, C. E. Gargett, H. Kalbacher, and H. J. Buhring. The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev. 2009; 19: 669-77.
21. Russell, W. E., R. J. Coffey, Jr., A. J. Ouellette, and H. L. Moses. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A. 1988; 85: 5126-5130.
22. Yamamoto, K., T. Awogi, K. Okuyama, and N. Takahashi. Nuclear localization of alkaline phosphatase in cultured human cancer cells. Med. Electron Microsc. 2003; 36: 47-51.
23. Changchien, C. S., C. L. Chen, Y. H. Yen, J. H. Wang, T. H. Hu, C. M. Lee, C. C. Wang, Y. F. Cheng, Y. J. Huang, C. Y. Lin, and S. N. Lu. Analysis of 6, 381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J. Gastroenterol. 2008; 43: 159-170.